xylazine

1 articles
BenzingaBenzinga··Prnewswire

Orexo Charts New Course with R&D Day Showcase of AmorphOX Pipeline

Orexo invites investors to March 24 R&D Day in Stockholm to present post-Zubsolv strategy, featuring AmorphOX technology and pipeline programs OX640 and OX390.
ORXOYpipelinestrategic priorities